Medicine guide
Alhemo 150 mg/1.5 ml
As listed in the register: Alhemo 150 mg/1.5 ml, Injektionslösung im Fertigpen
150 mg/1.5 ml ·
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Concizumabum
- Used in
- Blood, clotting and anaemia
- Made by
- Novo Nordisk Pharma AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Hämophilie A mit Inhibitoren, Hämophilie B mit Inhibitoren, schwere Hämophilie A ohne Inhibitoren und mittelschwere/schwere Hämophilie B ohne Inhibitoren.
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Novo Nordisk Pharma AG |
|---|---|
| Active substance | Concizumabum |
| Used in | Blood, clotting and anaemia |
| Strength | 150 mg/1.5 ml |
| Classification | B02BX · Blood, clotting and anaemia |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Alhemo 150 mg/1.5 ml, Injektionslösung im Fertigpen |
| Packs | 1 Fertigpen |
| Zulassungsnummer | 68844 |
| Dosisstärke | 3 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.